市場調查報告書
商品編碼
1497880
經腸營養製劑市場:按產品、類別、應用、分銷管道和最終用戶 - 2024-2030 年全球預測Enteral Feeding Formulas Market by Product (Disease-Specific Formulas, Standard Formulas), Category (Adult Formula, Pediatric Formula), Application, Distribution Channel, End-Users - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
經腸營養製劑市場規模預計2023年為61億美元,預計2024年將達到65.9億美元,2030年將達到105.4億美元,複合年成長率為8.11%。
經腸營養配方食品是專為無法口服食物但胃腸道功能正常的人設計的飲食治療方法。這些製劑透過管子直接輸送到胃和腸,用於提供完整或補充營養。這種專門的營養補充對於患有嚴重疾病、吞嚥困難、胃腸功能障礙或手術後恢復的患者至關重要,可以可靠地攝取改善或維持健康所需的必需營養素。世界上不斷成長的老年人口,更容易患慢性疾病和疾病,增加了對經腸營養製劑的需求。醫療保健提供者和患者對經腸營養益處的認知不斷提高,包括其在促進康復過程和減少住院時間方面的作用,正在推動經腸營養製劑市場的成長。在某些情況下對腸外營養的日益偏好正在阻礙市場成長。配方和輸送系統的不斷改進使經腸營養產品更安全、更有效率,這為經腸營養配方創造了成長機會。
主要市場統計 | |
---|---|
基準年[2023] | 61億美元 |
預測年份 [2024] | 65.9億美元 |
預測年份 [2030] | 105.4億美元 |
複合年成長率(%) | 8.11% |
區域洞察
在美洲,由於先進的醫療基礎設施、慢性病的高盛行率以及人口老化的加劇,經腸營養市場高度發達,所有這些都需要使用經腸營養解決方案。此外,該地區顯著採用了技術先進的產品和嚴格的指導方針,確保經腸營養的高品質標準,進一步推動市場成長。由於人們對經腸營養益處的認知不斷提高、醫療保健支出不斷增加以及全部區域醫療保健設施的改善,亞太地區經腸營養製劑市場正在快速成長。在中國和印度等人口眾多的國家,患有慢性疾病和營養不良的患者數量正在迅速增加,增加了對經腸營養製劑的需求。歐洲、中東和非洲地區呈現多元化的市場格局。歐洲因其完善的醫療保健系統、慢性病患病率高以及主要經腸營養製造商的強大影響力而在該地區處於領先地位。由於醫療基礎設施投資增加和臨床營養意識不斷增強,中東和非洲市場顯示出成長潛力。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在經腸營養製劑市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對經腸營養產品市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對經腸營養製劑市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[187 Pages Report] The Enteral Feeding Formulas Market size was estimated at USD 6.10 billion in 2023 and expected to reach USD 6.59 billion in 2024, at a CAGR 8.11% to reach USD 10.54 billion by 2030.
Enteral feeding formulas are dietary solutions designed for individuals who are unable to consume food orally but have a functioning digestive tract. These formulas are delivered through tubes directly into the stomach or intestine and are formulated to provide complete or supplemental nutrition. This specialized nutrition support is critical for patients who are critically ill, have swallowing difficulties, or gastrointestinal dysfunction, or are recovering from surgery, ensuring they receive the necessary nutrients to improve or maintain their health. The global increase in the elderly population who are prone to chronic conditions and diseases is necesistating the need for enteral feeding formulas. Growing awareness among healthcare providers and patients about the benefits of enteral nutrition, including its role in enhancing the recovery process and reducing hospital stays is driving the growth of the enteral feeding formulas market. Growing preference for parenteral nutrition in certain conditions hampers the growth of the market. Ongoing improvements in the formulation and delivery systems of enteral feeding products that make them safer and more efficient are creating opportunities for the growth of enteral feeding formulas.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 6.10 billion |
Estimated Year [2024] | USD 6.59 billion |
Forecast Year [2030] | USD 10.54 billion |
CAGR (%) | 8.11% |
Regional Insights
In the Americas, the market for eternal feeding is highly developing due to its advanced healthcare infrastructure, high prevalence of chronic diseases, and growing aging population, all of which necessitate the use of enteral feeding solutions. Additionally, the region observes a significant adoption of technologically advanced products and has stringent guidelines ensuring high-quality standards for enteral nutrition, further driving the market growth. The APAC region is witnessing rapid growth in the enteral feeding formulas market, attributed to the rising awareness about the benefits of enteral nutrition, increasing healthcare spending, and improvements in healthcare facilities across the region. Countries including China and India, with their large populations, are seeing a surge in the number of patients suffering from chronic conditions and malnutrition, which boosts the need for enteral feeding formulas. The EMEA region exhibits a diverse market landscape. Europe leads in the region due to its well-established healthcare systems, high prevalence of chronic diseases, and strong presence of leading enteral formula manufacturers. The market in the Middle East and Africa shows potential for growth due to increasing investments in healthcare infrastructure and growing awareness about clinical nutrition.
Market Insights
The market dynamics represent an ever-changing landscape of the Enteral Feeding Formulas Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Enteral Feeding Formulas Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Enteral Feeding Formulas Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Vygon Introduces Innovative Nutrisafe2 Feeding System for Enhanced Neonatal Care
Vygon launched the Nutrisafe2 feeding system, specifically engineered to meet the delicate nutritional needs of neonates. This advanced system is designed to offer a safer, more accurate method of enteral feeding for newborns, addressing the critical importance of nutrition during the early stages of life. The Nutrisafe2 system is distinguished by its unique safety features that minimize the risks associated with enteral feeding practices, such as misconnections and the inadvertent delivery of incorrect nutritional doses. [Published On: 2024-03-18]
Kate Farms Introduces Whole Food-Based Enteral Feeding Solutions
Kate Farms introduced whole-food blended meals specifically designed for enteral feeding, presented in user-friendly, resealable pouches. This development is noteworthy as these pouches are engineered to seamlessly connect with commonly used tube feeding devices, promoting ease of use. The product line epitomizes a blend of nutritional science and convenience, catering to the essential dietary needs of individuals dependent on tube feeding for sustenance. [Published On: 2023-11-01]
Nestle Health Science Invests USD 43 Million in Advanced Enteral Feeding Formula Facility
Nestle Health Science is significantly enhancing its manufacturing capabilities in Eau Claire, Wisconsin, through a substantial USD 43 million investment. This strategic financial infusion aims to expand and upgrade the facility's operations, particularly focusing on producing enteral feeding formulas. These specialized nutritional solutions are essential in medical settings, providing vital nourishment for patients unable to consume food orally. [Published On: 2023-01-18]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Enteral Feeding Formulas Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Enteral Feeding Formulas Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Ltd, B. Braun SE, Danone S.A., Fresenius Kabi AG, Global Health Products, Inc., Hormel Foods Corporation, Johnson & Johnson Services, Inc, Kate Farms, Inc., Medline Industries, Inc., Medtrition, Inc., Meiji Holdings Co., Ltd, Nestle SA, Nutricia North America, Otsuka Holdings Co., Ltd, Primus Pharmaceuticals, Inc., Real Food Blends by Nutrica, Reckitt Benckiser Group plc., and Victus, Inc..
Market Segmentation & Coverage